
This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.

Dr. Backer discusses assessing remission in CRSwNP by evaluating the patient's sense of smell in this video clip from the EAACI 2024 symposium.

Prof. Hellings and Prof. Corso explain that the right time to implement a biologic depends on academic and reimbursement criteria, which vary by country.

Prof. Hellings and Prof. Corso highlight that disease severity plays a key role in rate and control of remission in CRS.

Prof. Hellings and Prof. Corso discuss the significance and rationale behind the new definition of CRSwNP.

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

Dr. Ramien explores how advanced systemic therapies may modify atopic dermatitis pathomechanisms including skin barrier dysfunction, and neuroimmune dysregulation

An interactive tool highlighting the disease burden, impact and management of prurigo nodularis throughout the patient journey before diagnosis, during diagnosis and during treatment.
Dr. Dhandapani Ashok highlights treatment options for patients with EoE aged 12 years and younger and the importance of shared decision-making.
Prof. Greuter presents clinical data for approved treatments for adult EoE.

Presentation highlights from the ADVENT symposium at the EAACI 2023 congress in Hamburg, Germany.

This podcast episode discusses best practices for the diagnosis of atopic dermatitis of the hands and feet, as well as current and emerging treatment options.